Description
VIGLIPTIN M 50/500mg Tablets are a crucial prescription-only medication available at Gathimaini Pharmacy in Thika, Kenya, used for the comprehensive management of Type 2 Diabetes Mellitus. Each tablet contains a fixed-dose combination of Vildagliptin 50mg and Metformin Hydrochloride 500mg. This combination therapy targets multiple pathways to control blood sugar: Vildagliptin (a DPP-4 inhibitor) increases insulin release from the pancreas after meals and decreases the production of glucagon, while Metformin (a biguanide) reduces glucose production in the liver, decreases glucose absorption from the intestine, and improves the body’s sensitivity to insulin. VIGLIPTIN M 50/500mg is often prescribed when diet and exercise alone, or monotherapy with either vildagliptin or metformin, are not sufficient to achieve adequate blood sugar control. It helps improve both fasting and post-meal blood glucose levels, reducing the risk of long-term diabetes complications, and is suitable for initial combination therapy.
